34026-01-2

Usage

Uses

Used in Fragrance Industry:
2,2,6-Trimethylcyclohexanemethanol is utilized as a fragrance ingredient in various personal care and household products due to its mild and pleasant odor, enhancing the sensory experience of these products.
Used in Cleaning Products:
In the cleaning products industry, 2,2,6-trimethylcyclohexanemethanol serves as a solvent, contributing to the effectiveness of the cleaning formulations by helping dissolve various substances.
Used in Adhesives:
2,2,6-Trimethylcyclohexanemethanol is employed as a solvent in adhesive formulations, improving the adhesive's performance by acting as a carrier for other components and facilitating the bonding process.
Used in Industrial Coatings:
2,2,6-trimethylcyclohexanemethanol is also used in industrial coatings as a solvent, where it aids in the application process and the drying of the coating, ensuring a smooth and even finish.
Overall, 2,2,6-trimethylcyclohexanemethanol's versatility in different applications across various industries is attributed to its stability, pleasant odor, and low toxicity, making it a valuable component in the development of consumer and industrial products.

InChI:InChI=1/C10H20O/c1-8-5-4-6-10(2,3)9(8)7-11/h8-9,11H,4-7H2,1-3H3

Upstream product

• 52567-47-2 (+/-)-2.2.6c-trimethyl-cyclohexane-carboxylic acid-(1r)-methyl ester 
• 52567-47-2 (+/-)-2.2.6t-trimethyl-cyclohexane-carboxylic acid-(1r)-methyl ester 
• 4351-02-4 (+/-)-2,2,6c-trimethyl-cyclohexane-r-carboxylic acid 
• 432-25-7 2,6,6-trimethylcyclohex-1-enecarbaldehyde 
• 4350-74-7 (1R,6S)-2,2,6-trimethylcyclohexyl carbaldehyde 
• 693778-98-2 C-(2,2,6-trimethyl-cyclohexyl)-methylamine 

Downstream Products

• 4350-74-7 cis-2,2,6-trimethylcyclohexanecarboxaldehyde 
• 4350-74-7 trans-2,2,6-trimethylcyclohexanecarboxaldehyde 

Relevant academic research and scientific papers

RUTHENIUM COMPLEX, METHOD FOR PRODUCING SAME, AND USE OF SAME

The present invention provides a novel ruthenium complex that is easy to produce and handle and that can be supplied relatively inexpensively, a method for producing this ruthenium complex, a method for producing alcohols and the like using this ruthenium complex as a catalyst, a method for producing carbonyl compounds using this ruthenium complex as a catalyst, and a method for producing N-alkylamine compounds using this ruthenium complex as a catalyst. The present invention pertains to a ruthenium complex represented by general formula (1) RuX1X2(PNP) (NHC)m(Solv)n(1) (in general formula (1), X1 and X2 each independently represent a monovalent anionic monodentate ligand; PNP represents a tridentate aminodiphosphine ligand, NHC represents an N-heterocyclic carbene derived from a nitrogen-containing heterocyclic ring, and Solv represents a coordinating solvent; and m represents an integer from 1 to 3, n represents an integer from 0 to 2, and 1≦m+n≦3.), a method for producing the same, a catalyst including the same, and methods for producing various organic compounds using this catalyst.

General and highly efficient iron-catalyzed hydrogenation of aldehydes, ketones, and α,β-unsaturated aldehydes

EnvIRONmentally friendly: The title hydrogenation of aldehydes, ketones, and α,β-unsaturated aldehydes is reported. In the presence of the catalyst 1, primary, secondary, and allylic alcohols were obtained in good to excellent yields under mild reaction conditions. The catalyst is easily and inexpensively prepared, and is also stable to air, water, and column chromatography. Copyright

Discrete iron complexes for the selective catalytic reduction of aromatic, aliphatic, and α,β-unsaturated aldehydes under water-gas shift conditions

Iron-catalyzed reductions: Selective iron-catalyzed reduction of aldehydes with hydrogen generated in situ by the water-gas shift reaction is presented (see scheme). The generality and selectivity of this mild procedure are demonstrated by the efficient reduction of various aromatic, aliphatic and α,β-unsaturated aldehydes.

OPSIN-BINDING LIGANDS, COMPOSITIONS AND METHODS OF USE

Compounds and compositions of said compounds along with methods of use of compounds are disclosed for treating ophthalmic conditions related to mislocalization of opsin proteins, the misfolding of mutant opsin proteins and the production of toxic visual cycle products that accumulate in the eye. Compounds and compositions useful in the these methods, either alone or in combination with other therapeutic agents, are also described.